Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Privia Health (PRVA) Operating Expenses (2020 - 2025)

Historic Operating Expenses for Privia Health (PRVA) over the last 6 years, with Q3 2025 value amounting to $566.0 million.

  • Privia Health's Operating Expenses rose 3098.95% to $566.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 1827.19%. This contributed to the annual value of $1.7 billion for FY2024, which is 502.84% up from last year.
  • Per Privia Health's latest filing, its Operating Expenses stood at $566.0 million for Q3 2025, which was up 3098.95% from $517.8 million recorded in Q2 2025.
  • Privia Health's Operating Expenses' 5-year high stood at $566.0 million during Q3 2025, with a 5-year trough of $205.7 million in Q1 2021.
  • For the 5-year period, Privia Health's Operating Expenses averaged around $393.4 million, with its median value being $411.7 million (2023).
  • As far as peak fluctuations go, Privia Health's Operating Expenses surged by 13657.73% in 2021, and later crashed by 1865.58% in 2022.
  • Quarter analysis of 5 years shows Privia Health's Operating Expenses stood at $294.7 million in 2021, then rose by 22.9% to $362.2 million in 2022, then rose by 21.32% to $439.4 million in 2023, then grew by 3.7% to $455.7 million in 2024, then rose by 24.22% to $566.0 million in 2025.
  • Its Operating Expenses was $566.0 million in Q3 2025, compared to $517.8 million in Q2 2025 and $474.9 million in Q1 2025.